Your session is about to expire
← Back to Search
Behavioral Intervention
Passive Arm #1 for Colorectal Cancer (EPICS Trial)
N/A
Waitlist Available
Led By Daniel S. Blumenthal, MD, MPH
Research Sponsored by Morehouse School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
African Americans, 50-74 years of age, who are not current on CRC screening, are eligible for study participation
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 60 months
Awards & highlights
EPICS Trial Summary
Hypothesis 1. When compared to passive dissemination, active dissemination will result in greater participant enrollment. Hypothesis 2. The intervention will be offered with equal fidelity in churches, clinics and community sites. Hypothesis 3. Knowledge of CRC screening and perceived risk of CRC will be positively correlated.
Eligible Conditions
- Colorectal Cancer
EPICS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowEPICS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 60 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 60 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Effectiveness (RE-AIM Framework)
Reach (RE-AIM Framework)
Secondary outcome measures
Adoption (RE-AIM Framework)
Implementation (RE-AIM Framework)
Other outcome measures
Cost-effectiveness analysis
Maintenance (RE-AIM Framework)
EPICS Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Passive Arm #2Experimental Treatment1 Intervention
Active Arm #1, #2; Passive Arm #1, #2 Community coalitions randomized to the Passive Arm #2-Web Access With Technical Assistance will receive access to EPICS facilitator training materials and toolkits via the Research-Tested Intervention Programs (RTIPs) website and will participate in monthly technical assistance teleconferences.
Group II: Passive Arm #1Experimental Treatment1 Intervention
Active Arm #1, 2; Passive Arm #1, 2 Community coalitions randomized to the Passive Arm #1-Web Access Without Technical Assistance will receive access to EPICS facilitator training materials and toolkits via the Research-Tested Intervention Programs (RTIPs) website and will not participate in monthly technical assistance teleconferences.
Group III: Active Arm #1Active Control1 Intervention
Active Arm #1, #2; Passive Arm #1, #2 Community coalitions randomized to Active Arm #1-In-Person Access Without Technical Assistance will receive training from intervention developers with access to facilitator training materials but will not participate in monthly technical assistance teleconferences.
Group IV: Active Arm #2Active Control1 Intervention
Active Arm #1, #2; Passive Arm #1, #2 Community coalitions randomized to Active Arm #2-In-Person Access with Technical Assistance will receive training from intervention developers with access to facilitator training materials and will participate in monthly technical assistance teleconferences.
Find a Location
Who is running the clinical trial?
Morehouse School of MedicineLead Sponsor
20 Previous Clinical Trials
8,951 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,662 Previous Clinical Trials
40,918,681 Total Patients Enrolled
Daniel S. Blumenthal, MD, MPHPrincipal InvestigatorMorehouse School of Medicine
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger